Calidi Biotherapeutics (CLDI) Minority Interest (2024 - 2025)
Calidi Biotherapeutics' quarterly Minority Interest came in at $280000.0 in Q3 2025, down 42.27% year-on-year from $485000.0 in Q3 2024, and down 10.26% quarter-over-quarter from $312000.0 in Q2 2025.
Calidi Biotherapeutics has reported Minority Interest for 2 years, with the latest figure at $280000.0 in Q3 2025.
- For the quarter ending Q3 2025, Minority Interest fell 42.27% year-over-year to $280000.0; the trailing twelve-month figure through Sep 2025 stood at $280000.0 (down 42.27% YoY), and the FY2024 full-year result was $434000.0, changed N/A from the prior year.
- Minority Interest for Q3 2025 stood at $280000.0, down from $312000.0 in the prior quarter.
- The five-year high for Minority Interest was $485000.0 in Q3 2024, with the low at $280000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Sep 30, 2024 | 485,000.00 |